Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Traffic. 2009 Dec 3;11(3):348–360. doi: 10.1111/j.1600-0854.2009.01022.x

Fig. 5. Effect of sialidase or EGCase treatment on the distribution of Cav1 and PTRF-Cavin.

Fig. 5

HSFs were treated with or without the indicated enzyme for 30 min at 37°C followed by immunostaining of Cav1 (red) and PTRF-Cavin (green). Note the typical surface-like staining of Cav1 and extensive co-localization with PTRF-Cavin in control cells, while in sialidase- or EGCase-treated cells these proteins were non-overlapping and in different structures. Arrows indicate Golgi region. Bars, 10 µm.